ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267405.1	Lenalidomide	Bladder urothelial carcinoma	0.001340626	Sensitive
ENSG00000267405.1	Lenalidomide	Skin cutaneous melanoma	0.026829224	Sensitive